Impact of Contrast-Induced Nephropathy on Long-Term Renal Function after Coronary Angiography and Contrast-Enhanced Computed Tomography.

Cardiology and cardiovascular medicine Pub Date : 2022-01-01 Epub Date: 2022-09-16 DOI:10.26502/fccm.92920285
Hidekazu Moriya, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Kyoko Maesato, Mizuki Yamano, Hiroyuki Suzuki, Takayasu Ohtake, Sumi Hidaka, Shuzo Kobayashi
{"title":"Impact of Contrast-Induced Nephropathy on Long-Term Renal Function after Coronary Angiography and Contrast-Enhanced Computed Tomography.","authors":"Hidekazu Moriya,&nbsp;Yasuhiro Mochida,&nbsp;Kunihiro Ishioka,&nbsp;Machiko Oka,&nbsp;Kyoko Maesato,&nbsp;Mizuki Yamano,&nbsp;Hiroyuki Suzuki,&nbsp;Takayasu Ohtake,&nbsp;Sumi Hidaka,&nbsp;Shuzo Kobayashi","doi":"10.26502/fccm.92920285","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It remains unclear whether contrast-induced nephropathy (CIN) has a prognostic impact on subsequent renal dysfunction and whether deteriorating renal function is a risk factor for CIN. This study aimed to evaluate the occurrence of CIN in patients with pre-existing renal dysfunction and investigate the long-term effects of worsening renal function after coronary angiography or contrast-enhanced computed tomography (CT). The prognostic factors of worsening renal dysfunction were also analyzed.</p><p><strong>Methods: </strong>This was a prospective cohort study of patients at risk for CIN, defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m<sup>2</sup> on coronary angiography or eGFR <45 mL/min/1.73 m<sup>2</sup> on contrast-enhanced CT. Serum creatinine levels and the 2-year prognosis were evaluated. CIN was defined as an increase in serum creatinine level by more than 0.5 mg/dL or a 25% increase from the previous value within 72 hours after contrast administration. The primary endpoint was the proportion of patients who had serum Cr doubling or induction of dialysis within 2 years according to CIN occurrence.</p><p><strong>Results: </strong>Of the 410 patients, 19 patients developed CIN (8/142 patients on coronary angiography and 11/268 patients on contrast-enhanced CT), and 38 patients had worsened renal function (21/142 patients on coronary angiography and 17/268 patients on contrast-enhanced CT). CIN was not associated with worsening renal function at 2 years. Analysis by renal function at the time of coronary angiography or contrast-enhanced CT (i.e., eGFR ≥30 ml/min/1.73 m<sup>2</sup> and eGFR ≤1.73 m<sup>2</sup>) found no between-group difference in the occurrence of CIN.</p><p><strong>Conclusions: </strong>CIN is not a prognostic risk factor for the long-term of chronic kidney disease after coronary angiography or contrast-enhanced CT. Pre-existing renal dysfunction is also not a risk factor for CIN, even if the eGFR is <30 ml/min/1.73 m<sup>2</sup>.</p>","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"6 5","pages":"473-479"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536241/pdf/nihms-1838150.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology and cardiovascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/fccm.92920285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: It remains unclear whether contrast-induced nephropathy (CIN) has a prognostic impact on subsequent renal dysfunction and whether deteriorating renal function is a risk factor for CIN. This study aimed to evaluate the occurrence of CIN in patients with pre-existing renal dysfunction and investigate the long-term effects of worsening renal function after coronary angiography or contrast-enhanced computed tomography (CT). The prognostic factors of worsening renal dysfunction were also analyzed.

Methods: This was a prospective cohort study of patients at risk for CIN, defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 on coronary angiography or eGFR <45 mL/min/1.73 m2 on contrast-enhanced CT. Serum creatinine levels and the 2-year prognosis were evaluated. CIN was defined as an increase in serum creatinine level by more than 0.5 mg/dL or a 25% increase from the previous value within 72 hours after contrast administration. The primary endpoint was the proportion of patients who had serum Cr doubling or induction of dialysis within 2 years according to CIN occurrence.

Results: Of the 410 patients, 19 patients developed CIN (8/142 patients on coronary angiography and 11/268 patients on contrast-enhanced CT), and 38 patients had worsened renal function (21/142 patients on coronary angiography and 17/268 patients on contrast-enhanced CT). CIN was not associated with worsening renal function at 2 years. Analysis by renal function at the time of coronary angiography or contrast-enhanced CT (i.e., eGFR ≥30 ml/min/1.73 m2 and eGFR ≤1.73 m2) found no between-group difference in the occurrence of CIN.

Conclusions: CIN is not a prognostic risk factor for the long-term of chronic kidney disease after coronary angiography or contrast-enhanced CT. Pre-existing renal dysfunction is also not a risk factor for CIN, even if the eGFR is <30 ml/min/1.73 m2.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
造影剂肾病对冠状动脉造影和增强计算机断层扫描后长期肾功能的影响。
背景:造影剂肾病(CIN)是否对后续肾功能障碍有预后影响以及肾功能恶化是否是CIN的危险因素尚不清楚。本研究旨在评估已有肾功能不全患者发生CIN的情况,并探讨冠状动脉造影或增强CT (contrast-enhanced computed tomography, CT)后肾功能恶化的长期影响。并分析肾功能不全恶化的预后因素。方法:这是一项前瞻性队列研究,研究对象是有CIN风险的患者,定义为冠状动脉造影估计的肾小球滤过率(eGFR) 2或增强CT估计的eGFR 2。评估血清肌酐水平和2年预后。CIN定义为对比剂给药后72小时内血清肌酐水平比前值增加超过0.5 mg/dL或增加25%。主要终点是根据CIN发生情况,2年内血清Cr翻倍或诱导透析的患者比例。结果:410例患者中,19例发生CIN(冠状动脉造影8/142,CT增强11/268),38例肾功能恶化(冠状动脉造影21/142,CT增强17/268)。2年时,CIN与肾功能恶化无关。通过冠脉造影或增强CT时的肾功能分析(即eGFR≥30 ml/min/1.73 m2和eGFR≤1.73 m2),两组间CIN的发生无差异。结论:在冠状动脉造影或增强CT后,CIN不是慢性肾脏疾病的长期预后危险因素。即使eGFR为2,先前存在的肾功能不全也不是CIN的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health. Interaction between Perivascular and Luminal Factors in Arteriovenous Fistula in Yucatan Miniswine. Atrial fibrillation in Retinal Artery Occlusions. Immunomodulation and Thrombolytic Approaches in the Management of Deep Vein Thrombosis and Pulmonary Embolism. Apolipoprotein B in the Risk Assessment, Diagnosis, and Treatment of Cardiometabolic Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1